AIDSmeds.com newsletter
<http://www.aidsmeds.com/>
*News From AIDSmeds.com and Reuters Health *


January 23, 2007

Selenium Treatment Beneficial in HIV
(AIDSmeds.com) A new research paper suggests that selenium
supplementation is associated with significant health benefits in
HIV-positive people, including stabilized viral loads and moderate
CD4 count gains. The nine-month placebo-controlled study, conducted
by investigators at the University of Miami, was reported in the
January 22 issue of the American Medical Association's Archives
of Internal Medicine.


January 22, 2007

Risk of BCG Infection in Positive Infants
(Reuters Health) HIV-infected children who have been given BCG
(Bacille Calmette Guerin) vaccine are at high risk of developing
disseminated BCG disease, researchers from South Africa report.


January 18, 2007

AIDS Dementia Predicts Time to Death
(Reuters Health) HIV-associated dementia independently predicts time
to death in patients with advanced HIV infection, according to a
report in the Archives of Neurology for January.


January 16, 2007

Lifespan Expanding for Patients with HIV
(Reuters Health) Although life expectancy is still significantly
reduced, young patients recently diagnosed with HIV have an estimated
median survival of more than 35 years, Danish researchers report in
the January issue of the Annals of Internal Medicine.


Nevirapine Works After Use in Pregnancy
(AIDSmeds.com) HIV-positive pregnant women who use single-dose
Viramune (nevirapine) during labor to prevent transmission of
the virus to their babies may still benefit from using the drug in a
complete treatment regimen to protect her own health, provided that
at least six months have passed since the time of delivery.


January 15, 2007

'Serosorting' Appears To Be Limiting Spread of HIV
(Reuters Health) Selection by men of sexual partners and behaviors
according to HIV status, a phenomenon called serosorting, influences
the spread of HIV and other sexually transmitted infections,
according to a report in the December 2006 issue of Sexually
Transmitted Infections.


January 10, 2007

Early Treatment Linked to CD4 Gains
(AIDSmeds.com) A new report suggests that early HIV treatment is
more likely to result in "normal" CD4 (T4 cell) counts, compared to
treatment started in accordance with current treatment guidelines.


*Heard from /The HIV Blogs/*

<http://blogs.poz.com/ann/>On the HIV front, my virus and I will be
commemorating ten years together and we just might toast it with a
cocktail. Last year saw my CD4s show a definite trend-- my
first ever. (Jan, 787, 32%; April, 628, 29%; July, 550, 26%; Oct,
447, 26% - VL at or below 18,400 through the year).

Many of you probably see where this is headed--to the corner
of Time2Start Boulevard and WhatCombo Drive. I've been cruising
down NoMeds Parkway for quite a while now and knew my exit would come
up sooner or later. I'm waiting for the next bit of map--
the labs I had done the other day. It's a Magical Mystery Tour
and each bit of lab work is a clue to the journey's next leg.

from "Buckle Up Tight and Strap on the Helmet!
<http://blogs.poz.com/ann/archives/2007/01/buckle_up_tight.html>"; in
/Ann's HIV Blog <http://blogs.poz.com/ann/>/
You can leave comments for Ann directly in her blog-- just
click the "Comments" link at the end of each blog entry.


Copyright 2007 Smart + Strong, 500 Fifth Avenue, Suite 320, New York,
NY 10110. All rights reserved.